CBCE Launches Continuing Education App for iPhone
The new app allows for fully accredited multimedia CME content such as treatment updates, conference highlights, and tests.
News
Foresight’s Conjunctivitis Solution Beats Competitors In Study
FST-100 performed significantly better than other treatments for adenoviral conjunctivitis, including the current experimental “gold standard” topical cidofovir.
FDA to Review Alternative Dosing Method for Bone Marrow Drug
Most people have never heard of myelodysplastic syndrome (MDS), but approximately 10,000 to 15,000 people in the U.S. are diagnosed with it every year.
Independent Study Validates BioNeutral’s Ygiene
In an independent study, BioNeutral’s Ygiene antimicrobial formulation eliminated a particularly dangerous type of mold in record time.
Positive Peer Review for Aureon’s Prostate Px+
The peer reviewed results published today in the Journal of Urology found that Aureon Laboratories’ Prostate Px+ test is twice as effective as other tools currently available at identifying which patients classified as intermediate-risk have high-risk, life-threatening cancer.
[Company Profile] Echo Therapeutics
Echo Therapeutics of Franklin, Mass., has developed the Symphony tCGM System, a needle-free, wireless system that allows patients to painlessly and accurately monitor their blood glucose levels around the clock.
Researchers Identify Lupus Trigger
Researchers identified three proteins, called Toll-Like Receptors (TLRs), that can cause the immune system to turn against the body.
CombinatoRx to Merge with Neuromed
CombinatoRx has signed an all-stock merger agreement with Neuromed.
Cynosure, Unilever Join Forces to Develop Home-Use Aesthetic Devices
The multi-year agreement will focus on the skin rejuvenation segment of the marketplace.
AST to Resume Clinical Trials of Spinal Stabilization Device
Applied Spine Technologies has received permission from the FDA to restart a clinical trial of Stabilimax NZ.